Circulating plasma miR222-3P status and its potential diagnostic performance in prostate cancer.
Zohreh HeydariEmadoddin MoudiFarzin SadeghiMahmoud HajiahmadiSetareh RezatabarNahid NeamatiHadi ParsianPublished in: The journal of gene medicine (2022)
Circulating plasma miR-222-3p significantly upregulated in PC patients, but not in BPH ones. Besides these preliminary results showed that miR222-3p has the potential to discriminate PC patients from healthy ones. Addittional studies with a larger sample size are required to confirm these data.